{"id":"W2144939065","doi":"10.1016/j.jacc.2012.02.008","title":"New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes","year":2012,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":267,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University","funders":"Schering-Plough; Roche; GlaxoSmithKline; Pfizer","keywords":"Medicine; Rivaroxaban; Apixaban; Edoxaban; Dabigatran; Atrial fibrillation; Warfarin; Stroke (engine); Cardiology; Internal medicine; Direct thrombin inhibitor; Anesthesia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005342011,0.0002230512,0.003949701,0.0003840855,0.00002596519,0.000003837976,0.0001611679,0.0001234243,0.00001064936],"category_scores_gemma":[0.0001384988,0.0001322113,0.001257896,0.0004624022,0.0001766689,0.00007183464,0.0001389563,0.0002500334,0.000002303617],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009424361,"about_ca_system_score_gemma":0.0003865344,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008952997,"about_ca_topic_score_gemma":0.000001389665,"domain_scores_codex":[0.9979859,0.0004582707,0.0009709075,0.0001267774,0.0002627634,0.0001953552],"domain_scores_gemma":[0.9973787,0.0003804607,0.001848991,0.0002247209,0.00006680217,0.0001002948],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008439631,0.000001248577,0.2621181,0.00110488,0.004321808,0.0002957928,0.00001349874,0.00004542222,0.000003612239,0.0001070417,0.001783973,0.7293606],"study_design_scores_gemma":[0.001272126,0.0005175556,0.1076144,0.001381607,0.008262372,0.007985578,0.00003166974,0.000003222212,3.285243e-7,0.00005279968,0.8727306,0.0001477674],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01447928,0.9830041,0.00004753731,0.0006594887,0.001071462,0.0005898991,0.00004115335,0.000004520663,0.0001025506],"genre_scores_gemma":[0.01835999,0.9776034,0.0007137635,0.00001714626,0.002839686,1.266164e-7,0.000005060826,0.00002330551,0.0004374772],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8709466,"threshold_uncertainty_score":0.5391418,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09045453171110361,"score_gpt":0.3783420554777537,"score_spread":0.2878875237666501,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}